Dental firm vVardis reveals revenue surge in US IPO filing
- Revenue triples in surprise US IPO filing
- Company bets big on American dental market
- Swiss-based firm seeks slice of the retail dental pie
Advertisement | Scroll to Continue
Brief Summary
Dental outfit vVardis is making a play for American capital, filing for a US IPO after claiming a massive revenue spike in the first half of the year. The company, which specializes in enamel-repair technology, is looking to capitalize on the lucrative US dental market by inviting investors to get in on the ground floor of their growth narrative.
Why This Matters
If you are looking for the next niche healthcare play, this is another ticker to watch, though dental tech IPOs often come with more polish than substance. Expect to see their products pushed harder in your dentist's office as they ramp up marketing to justify the valuation they are chasing on the public markets.
You Might Also LikeAdvertisement